Related references
Note: Only part of the references are listed.Treatment of Advanced Melanoma in 2020 and Beyond
Russell W. Jenkins et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
Patients with Metastatic Melanoma Receiving Anticancer Drugs: Changes in Overall Survival, 2010-2017
Florence Poizeau et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Triptolide delivery: Nanotechnology-based carrier systems to enhance efficacy and limit toxicity
Qing Ren et al.
PHARMACOLOGICAL RESEARCH (2021)
Extracellular vesicles versus synthetic nanoparticles for drug delivery
Kenneth W. Witwer et al.
NATURE REVIEWS MATERIALS (2021)
Engineered Extracellular Vesicles for Cancer Therapy
Xu Zhang et al.
ADVANCED MATERIALS (2021)
Nanocarrier-Based Drug Delivery for Melanoma Therapeutics
Mingming Song et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Recent Advancement and Technical Challenges in Developing Small Extracellular Vesicles for Cancer Drug Delivery
Tianjiao Geng et al.
PHARMACEUTICAL RESEARCH (2021)
Phosphatidylcholine-Engineered Exosomes for Enhanced Tumor Cell Uptake and Intracellular Antitumor Drug Delivery
Qi Zhan et al.
MACROMOLECULAR BIOSCIENCE (2021)
Passion fruit-like exosome-PMA/Au-BSA@Ce6 nanovehicles for real-time fluorescence imaging and enhanced targeted photodynamic therapy with deep penetration and superior retention behavior in tumor
Shaojun Pan et al.
BIOMATERIALS (2020)
TRAIL in oncology: From recombinant TRAIL to nano- and self-targeted TRAIL-based therapies
Hassan Dianat-Moghadam et al.
PHARMACOLOGICAL RESEARCH (2020)
The biology, function, and biomedical applications of exosomes
Raghu Kalluri et al.
SCIENCE (2020)
Extracellular Vesicle Delivery of TRAIL Eradicates Resistant Tumor Growth in Combination with CDK Inhibition by Dinaciclib
Changhong Ke et al.
CANCERS (2020)
A nanoparticle’s pathway into tumours
Irene de Lázaro et al.
NATURE MATERIALS (2020)
Triptolide inhibits pancreatic cancer cell proliferation and migration via down -regulating PLAU based on network pharmacology of Tripterygium wilfordii Hook F
Xin Zhao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo models
Michael C. Johnston et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Engineering Macrophages for Cancer Immunotherapy and Drug Delivery
Yuqiong Xia et al.
ADVANCED MATERIALS (2020)
TRAIL therapy and prospective developments for cancer treatment
Bindu Thapa et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Survivin modulation in the antimelanoma activity of prodiginines
Paola C. Branco et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Engineering macrophage-derived exosomes for targeted chemotherapy of triple-negative breast cancer
Sha Li et al.
NANOSCALE (2020)
Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium
Zhuo Wan et al.
THERANOSTICS (2020)
Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer Therapy
Javier Naval et al.
CANCERS (2019)
Exosomes: Diagnostic Biomarkers and Therapeutic Delivery Vehicles for Cancer
Liangdi Jiang et al.
MOLECULAR PHARMACEUTICS (2019)
TRAIL-based gene delivery and therapeutic strategies
Hui-hai Zhong et al.
ACTA PHARMACOLOGICA SINICA (2019)
Promotion of TRAIL/Apo2L-induced apoptosis by low-dose interferon-β in human malignant melanoma cells
Akira Kazaana et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer
Dnyaneshwar Kalyane et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2019)
The acidic tumor microenvironment: a target for smart cancer nano-theranostics
Liangzhu Feng et al.
NATIONAL SCIENCE REVIEW (2018)
Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy
Pedro P. G. Guimaraes et al.
ACS NANO (2018)
Broad targeting of triptolide to resistance and sensitization for cancer therapy
Zhen-yan Hou et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
New Technologies for Analysis of Extracellular Vesicles
Huilin Shao et al.
CHEMICAL REVIEWS (2018)
Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations
Myung Soo Kim et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Shedding light on the cell biology of extracellular vesicles
Guillaume van Niel et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Fluorescence colocalization microscopy analysis can be improved by combining object-recognition with pixel-intensity-correlation
Bernhard Moser et al.
BIOTECHNOLOGY JOURNAL (2017)
Fluorescence colocalization microscopy analysis can be improved by combining object-recognition with pixel-intensity-correlation
Bernhard Moser et al.
BIOTECHNOLOGY JOURNAL (2017)
TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy
ZhengQiang Yuan et al.
JOURNAL OF EXTRACELLULAR VESICLES (2017)
Extracellular vesicles for drug delivery
Pieter Vader et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Onto better TRAILs for cancer treatment
D. de Miguel et al.
CELL DEATH AND DIFFERENTIATION (2016)
Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells
Myung Soo Kim et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Mesenchymal stromal cell delivery of full-length tumor necrosis factor-related apoptosis-inducing ligand is superior to soluble type for cancer therapy
Zhengqiang Yuan et al.
CYTOTHERAPY (2015)
The Effect of High Glucose on Proliferation and Expression of Correlation Factors of MG63 Osteoblasts
Zhou Linxi et al.
Journal of Hard Tissue Biology (2015)
Liposome-bound TRAIL induces superior DR5 clustering and enhanced DISC recruitment in histiocytic lymphoma U937 cells
Diego De Miguel et al.
LEUKEMIA RESEARCH (2015)
Drug and cell encapsulation: Alternative delivery options for the treatment of malignant brain tumors
Swapnil V. Bhujbal et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Triptolide: Progress on research in pharmacodynamics and toxicology
Xiao-Jiaoyang Li et al.
JOURNAL OF ETHNOPHARMACOLOGY (2014)
Bioinspired Exosome-Mimetic Nanovesicles for Targeted Delivery of Chemotherapeutics to Malignant Tumors
Su Chul Jang et al.
ACS NANO (2013)
Triptolide-Mediated Apoptosis by Suppression of Focal Adhesion Kinase through Extrinsic and Intrinsic Pathways in Human Melanoma Cells
Haw-Young Kwon et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics
L. Y. Dimberg et al.
ONCOGENE (2013)
Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes
Fu-Shin Chueh et al.
ONCOLOGY REPORTS (2013)
Triptolide induces S phase arrest via the inhibition of cyclin E and CDC25A and triggers apoptosis via caspase- and mitochondrial-dependent signaling pathways in A375.S2 human melanoma cells
Fang-Ming Hung et al.
ONCOLOGY REPORTS (2013)
Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor
Yinghuan Li et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Triptolide Inhibits Proliferation and Induces Apoptosis of Human Melanoma A375 Cells
Yue Tao et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Preactivation of Human MSCs with TNF-α Enhances Tumor-Suppressive Activity
Ryang Hwa Lee et al.
CELL STEM CELL (2012)
The unfolded protein response: controlling cell fate decisions under ER stress and beyond
Claudio Hetz
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Triptolide Induces Apoptosis and Inhibits the Growth and Angiogenesis of Human Pancreatic Cancer Cells by Downregulating COX-2 and VEGF
Jian-Xia Ma et al.
ONCOLOGY RESEARCH (2012)
Promoting melanoma growth and metastasis by enhancing VEGF expression
Chun-sheng Ni et al.
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY (2012)
Protective and pathogenic functions of macrophage subsets
Peter J. Murray et al.
NATURE REVIEWS IMMUNOLOGY (2011)
New insights into apoptosis signaling by Apo2L/TRAIL
F. Gonzalvez et al.
ONCOGENE (2010)
Generation of a novel proform of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein that can be reactivated by matrix metalloproteinases
Jin Na Shin et al.
EXPERIMENTAL CELL RESEARCH (2006)
Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor
Almer M. van der Sloot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The pathophysiology of mitochondrial cell death
DR Green et al.
SCIENCE (2004)
Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L
R Di Pietro et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
High-efficiency lentiviral vector-mediated gene transfer into murine macrophages and activated splenic B lymphocytes
GR Rossi et al.
HUMAN GENE THERAPY (2003)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells
I Monleón et al.
JOURNAL OF IMMUNOLOGY (2001)
The role of NF-κB in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells
AV Franco et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
